-
The Past, Present, and Future of the Brain Imaging Data Structure (BIDS)
Authors:
Russell A. Poldrack,
Christopher J. Markiewicz,
Stefan Appelhoff,
Yoni K. Ashar,
Tibor Auer,
Sylvain Baillet,
Shashank Bansal,
Leandro Beltrachini,
Christian G. Benar,
Giacomo Bertazzoli,
Suyash Bhogawar,
Ross W. Blair,
Marta Bortoletto,
Mathieu Boudreau,
Teon L. Brooks,
Vince D. Calhoun,
Filippo Maria Castelli,
Patricia Clement,
Alexander L Cohen,
Julien Cohen-Adad,
Sasha D'Ambrosio,
Gilles de Hollander,
María de la iglesia-Vayá,
Alejandro de la Vega,
Arnaud Delorme
, et al. (89 additional authors not shown)
Abstract:
The Brain Imaging Data Structure (BIDS) is a community-driven standard for the organization of data and metadata from a growing range of neuroscience modalities. This paper is meant as a history of how the standard has developed and grown over time. We outline the principles behind the project, the mechanisms by which it has been extended, and some of the challenges being addressed as it evolves.…
▽ More
The Brain Imaging Data Structure (BIDS) is a community-driven standard for the organization of data and metadata from a growing range of neuroscience modalities. This paper is meant as a history of how the standard has developed and grown over time. We outline the principles behind the project, the mechanisms by which it has been extended, and some of the challenges being addressed as it evolves. We also discuss the lessons learned through the project, with the aim of enabling researchers in other domains to learn from the success of BIDS.
△ Less
Submitted 8 January, 2024; v1 submitted 11 September, 2023;
originally announced September 2023.
-
Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 2 -- Ex vivo imaging: added value and acquisition
Authors:
Kurt G Schilling,
Francesco Grussu,
Andrada Ianus,
Brian Hansen,
Amy FD Howard,
Rachel L C Barrett,
Manisha Aggarwal,
Stijn Michielse,
Fatima Nasrallah,
Warda Syeda,
Nian Wang,
Jelle Veraart,
Alard Roebroeck,
Andrew F Bagdasarian,
Cornelius Eichner,
Farshid Sepehrband,
Jan Zimmermann,
Lucas Soustelle,
Christien Bowman,
Benjamin C Tendler,
Andreea Hertanu,
Ben Jeurissen,
Lucio Frydman,
Yohan van de Looij,
David Hike
, et al. (32 additional authors not shown)
Abstract:
The value of preclinical diffusion MRI (dMRI) is substantial. While dMRI enables in vivo non-invasive characterization of tissue, ex vivo dMRI is increasingly used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages including higher signal-to-noise ratio and spatial resolution compared to in vivo studies, and enabling more advanced diffusion cont…
▽ More
The value of preclinical diffusion MRI (dMRI) is substantial. While dMRI enables in vivo non-invasive characterization of tissue, ex vivo dMRI is increasingly used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages including higher signal-to-noise ratio and spatial resolution compared to in vivo studies, and enabling more advanced diffusion contrasts. Another major advantage of ex vivo dMRI is the direct comparison with histological data as a methodological validation. However, there are a number of considerations that must be made when performing ex vivo experiments. The steps from tissue preparation, image acquisition and processing, and interpretation of results are complex, with decisions that not only differ dramatically from in vivo imaging of small animals, but ultimately affect what questions can be answered using the data. This work represents "Part 2" of a 3-part series of recommendations and considerations for preclinical dMRI. We describe best practices for dMRI of ex vivo tissue, with a focus on the value that ex vivo imaging adds to the field of dMRI and considerations in ex vivo image acquisition. We give general considerations and foundational knowledge that must be considered when designing experiments. We describe differences in specimens and models and discuss why some may be more or less appropriate for different studies. We then give guidelines for ex vivo protocols, including tissue fixation, sample preparation, and MR scanning. In each section, we attempt to provide guidelines and recommendations, but also highlight areas for which no guidelines exist (and why), and where future work should lie. An overarching goal herein is to enhance the rigor and reproducibility of ex vivo dMRI acquisitions and analyses, and thereby advance biomedical knowledge.
△ Less
Submitted 24 October, 2024; v1 submitted 27 September, 2022;
originally announced September 2022.
-
Considerations and Recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 1 -- In vivo small-animal imaging
Authors:
Ileana O Jelescu,
Francesco Grussu,
Andrada Ianus,
Brian Hansen,
Rachel L C Barrett,
Manisha Aggarwal,
Stijn Michielse,
Fatima Nasrallah,
Warda Syeda,
Nian Wang,
Jelle Veraart,
Alard Roebroeck,
Andrew F Bagdasarian,
Cornelius Eichner,
Farshid Sepehrband,
Jan Zimmermann,
Lucas Soustelle,
Christien Bowman,
Benjamin C Tendler,
Andreea Hertanu,
Ben Jeurissen,
Marleen Verhoye,
Lucio Frydman,
Yohan van de Looij,
David Hike
, et al. (32 additional authors not shown)
Abstract:
Small-animal diffusion MRI (dMRI) has been used for methodological development and validation, characterizing the biological basis of diffusion phenomena, and comparative anatomy. The steps from animal setup and monitoring, to acquisition, analysis, and interpretation are complex, with many decisions that may ultimately affect what questions can be answered using the resultant data. This work aims…
▽ More
Small-animal diffusion MRI (dMRI) has been used for methodological development and validation, characterizing the biological basis of diffusion phenomena, and comparative anatomy. The steps from animal setup and monitoring, to acquisition, analysis, and interpretation are complex, with many decisions that may ultimately affect what questions can be answered using the resultant data. This work aims to present selected recommendations and guidelines from the diffusion community, on best practices for preclinical dMRI of in vivo animals. We describe the general considerations and foundational knowledge that must be considered when designing experiments. We briefly describe differences in animal species and disease models and discuss why some may be more or less appropriate for different studies. We then give guidelines for in vivo acquisition protocols, including decisions on hardware, animal preparation, and imaging sequences, followed by advice for data processing including pre-processing, model-fitting, and tractography. Finally, we provide an online resource which lists publicly available preclinical dMRI datasets and software packages, to promote responsible and reproducible research. In each section, we attempt to provide guides and recommendations, but also highlight areas for which no guidelines exist (and why), and where future work should focus. While we mainly cover the central nervous system (on which most preclinical dMRI studies are focused), we also provide, where possible and applicable, recommendations for other organs of interest. An overarching goal herein is to enhance the rigor and reproducibility of small animal dMRI acquisitions and analyses, and thereby advance biomedical knowledge.
△ Less
Submitted 21 November, 2024; v1 submitted 26 September, 2022;
originally announced September 2022.
-
Promise and pitfalls of g-ratio estimation with MRI
Authors:
Jennifer S. W. Campbell,
Ilana R. Leppert,
Mathieu Boudreau,
Sridar Narayanan,
Tanguy Duval,
Julien Cohen-Adad,
G. Bruce Pike,
Nikola Stikov
Abstract:
The fiber g-ratio is the ratio of the inner to the outer diameter of the myelin sheath of a myelinated axon. It has a limited dynamic range in healthy white matter, as it is optimized for speed of signal conduction, cellular energetics, and spatial constraints. In vivo imaging of the g-ratio in health and disease would greatly increase our knowledge of the nervous system and our ability to diagnos…
▽ More
The fiber g-ratio is the ratio of the inner to the outer diameter of the myelin sheath of a myelinated axon. It has a limited dynamic range in healthy white matter, as it is optimized for speed of signal conduction, cellular energetics, and spatial constraints. In vivo imaging of the g-ratio in health and disease would greatly increase our knowledge of the nervous system and our ability to diagnose, monitor, and treat disease. MRI based g-ratio imaging was first conceived in 2011, and expanded to be feasible in full brain with preliminary results in 2013. This manuscript reviews the growing g-ratio imaging literature and speculates on future applications. It details the methodology for imaging the g-ratio with MRI, and describes the known pitfalls and challenges in doing so.
△ Less
Submitted 25 August, 2017; v1 submitted 10 January, 2017;
originally announced January 2017.